Filter
102
Filtered Results: 102
Text search:
A.
Silveira
Featured
Recommendations
6
New Publications
13
Language
Document type
No document type
50
Studies & Reports
24
Guidelines
17
Manuals
6
Strategic & Response Plan
3
Training Material
1
Fact sheets
1
Countries / Regions
Latin America and the Carribbean
13
Brazil
8
Global
3
Paraguay
3
India
3
Colombia
2
Haiti
2
Germany
2
North America
2
Russia
2
Indonesia
2
Kenya
1
Lesotho
1
Malawi
1
Zimbabwe
1
Philippines
1
Mozambique
1
Africa
1
Asia
1
Dominican Republic
1
Venezuela
1
Tanzania
1
Congo, Democratic Republic of
1
Western Pacific Region
1
Western and Central Europe
1
Eastern Europe
1
Namibia
1
Angola
1
Botswana
1
Zambia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Guidelines
11
COVID-19
10
Studies & Reports
10
Chagas
5
Disease Prevention & Control
5
Policies
4
Disaster Preparedness
3
Vector Control
3
Drugs & Medical Equipment
3
Clinical Training
2
Hepatitis
2
Public Health
2
Countries
2
Leishmaniasis
2
Pharmacy & Technology
1
Child Health
1
Trachoma
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Lymphaticfilariasis
1
Public Health
1
Snakebites
1
Child protection
1
Yellow Fever
1
Policies & Guidelines HIV & TB
1
Women & Child Health
1
Community Health
1
Information, Education and Communication (IEC)
1
Disabilities
1
Humanitarian Crisis
1
Other
1
Immunization
1
Gynaecology & Obstetrics
1
Health Systems
1
Leprosy
1
NTDs & Others
1
Dengue
1
Water
1
Age & Elderly
1
Neonatal Care
1
Reproductive Health
1
Toolboxes
Country specific documents
7
Latin America & the Carribean
5
Reports & Studies
5
Surveillance
4
Public Health
4
Latin America
4
Studies & Reports
4
TB & Prisoners
4
Global Impact: Socio-economic, health services, TB & HIV
3
Inactivated COVID-19 Vaccines
3
Chagas
3
Neurological Disorders
3
Alzheimer's Disease & Dementia
3
Yellow Fever Prevention & Control
2
Key Resources
2
Vaxzevria (Astra Zeneca)
2
Clinical Aspects & Diagnostics
2
Clinical Aspects & Diagnostics
2
Vector control
2
Leptospirosis
2
Substance Use Disorders & Addiction
2
Neurological disorders, Others
2
Best Practice Models
1
Natural Disaster
1
Advocacy
1
Key Resources
1
Agriculture & Veterinary
1
Posttraumatic stress disorder Adults
1
Children & Adolescents
1
Pediatrics
1
Policies & Programmes
1
Training Manuals
1
Dengue
1
Surveillance
1
Stigma & Discrimination
1
Others
1
Health Equity & Equality
1
International
1
Cannabis
1
COVID-19
1
For Parents & Children
1
Medical & Community Masks
1
RCCE Guides & Manuals
1
Vaccination & Strategy
1
Immunization Guidelines
1
Fair Allocation & Ethical Aspects
1
TB/COVID-19
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Standard Operating Procedure (SOP)
1
Self-care
1
Colombia
1
Brazil
1
Booster Doses
1
Urban health
1
Rational use of Medicine
1
Standard Operating Procedures (SOPs)
1
Traditional & Herbal Medicines
1
NTDs
1
Studies & Reports
1
Overview, Studies & Reports
1
Taeniasis/Cysticercosis
1
Studies & Reports
1
National Emergency Response Plans
1
Tobacco
1
Community-based Mental Health Care
1
Reports & Studies Children HIV
1
HIV in Key Populations
1
Public Health
1
Preparedness & Prevention
1
Treatment & Clinical Management
1
Advising principles. The purpose of this document is to support competent authorities in charge of IHR implementation to improve national capacities for the prevention, detection and control of events, by strengthening communications and coordination between points of entry and the national health s...
PLoS Med 15(7): e1002615. https://doi.org/10.1371/journal. pmed.1002615
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
Este informe se conforma del resumen ejecutivo, metodología, contextualización de la población migrante venezolana en República Dominicana, contextualización de la inversión y empresariado; un informe descriptivo de los resultados de campo; el impacto económico real e impacto económico poten...
Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
